CClinicalTrials.gg
RecruitingNCT05993221TRACTsUpdated Jun 6, 2025

Deconstructing Post Stroke Hemiparesis

An observational study in Stroke, sponsored by Providence VA Medical Center. Recruiting at 1 site in United States. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2025-06-06.

Sponsored by Providence VA Medical Center · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
75
Ages
18 Years to 90 Years
Sex
All
01

Study summary

TRACTs (DeconsTructing Post StRoke HemipAresis for PreCision NeurorehabiliTation) is a single timepoint study that aims to deconstruct post-stroke deficits of the upper extremity into distinct components and relate these components to brain anatomy and physiology.

Read the detailed description

Veterans will be recruited through the Providence Veterans Affairs Medical Center and will have research visits at the Providence VA Center for Neurorestoration and Neurotechnology (CfNN, centerforneuro.org). The research visits will span two to three days. The study will involve motor outcome measures, magnetic resonance imaging of the brain, and transcranial magnetic stimulation. The goal of this study is to associate post-stroke deficits of the upper extremity with brain anatomy and physiology.

02

Conditions studied

  • Stroke

Browse trials for

03

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Veterans who have sustained a unilateral ischemic stroke at least six months prior to recruitment with resulting upper extremity deficit(s).

Inclusion criteria

  • Diagnosis of a unilateral ischemic stroke occurring >6 months prior as documented in medical chart
  • Upper extremity motor impairment as measured by Fugl-Meyer Upper Extremity Assessment ≤60
  • Ability to follow simple instructions in English

Exclusion criteria

Exclusion Criteria:

  • Greater than moderate difficulty using the arm and hand pre-dating the stroke as assessed by the questions adapted from the QuickDASH outcome measure score on any question >= 3, which measures physical function and symptoms in people with difficulty using the arm and hand.
  • Visual or auditory disorders resulting in the inability to see or hear, respectively, the stimuli presented as part of research sessions
  • Inability to maintain a seated position for at least one hour
  • Standard MRI exclusion (e.g., significant claustrophobia or inability to tolerate loud noises, cardiac pacemaker (unless MRI-safe), implanted device (deep brain stimulation) or metal in the brain, cervical spinal cord, or upper thoracic spinal cord)
  • Standard (single-pulse) TMS exclusion which include (in addition to those listed for MRI) pregnancy/lactation/planning to become pregnant during the study, seizure disorder, and primary or secondary CNS tumors
04

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
75 participants (estimated)
Patient registry
No
05

What researchers measure

Primary outcomes

  1. Fugl-Meyer Arm Motor Assessment

    This test provides information about the level of upper extremity motor impairment after stroke. It consists of a 33-item assessment, which provides a global assessment of upper extremity motor impairment. A rater observes 30 voluntary upper extremity motions, two tendon tap responses, and provides an ordinal rating (2 = near normal ability/response, 1 = partial ability, 0 = unable to perform/no response). The Fugl-Meyer Upper Extremity scale has excellent intra-rater reliability (0.99), inter-rater reliability (0.99), test-retest reliability (0.94-0.99), and internal consistency (0.97).

    Time frame: Assessment occurs at one cross-sectional timepoint within 2 weeks of research consent

Secondary outcomes

  1. Edinburgh Handedness Inventory

    This screener is used to identify the handedness of participants prior to stroke by asking them which hand they typically use to complete activities of daily living, such as writing, throwing a ball, cutting paper with scissors, brushing teeth, and eating with a spoon. Participants can answer if they would use strictly their right hand, right more than left, both equally, left more than right, or strictly their left hand. Participants are then categorized as left-handed, ambidextrous, or right-handed.

    Time frame: Assessment occurs at one cross-sectional timepoint within 2 weeks of research consent

  2. Action Research Arm Test (ARAT)

    This test is used to assess upper limb performance post-stroke by measuring coordination, dexterity, and functioning. Participants are asked to complete tasks grouped into four categories - gross movement, grasp, grip, and pinch. Task performance is rated on a four point scale, in which 0 represents no movement and 3 represents normal movement. The Action Research Arm Test has demonstrated an inter-rater reliability between 0.996-0.998.

    Time frame: Assessment occurs at one cross-sectional timepoint within 2 weeks of research consent

  3. Modified Ashworth Scale

    This test is used to assess spasticity at different joints of the upper extremity. The test will be performed at the shoulder, elbow, forearm, wrist, and digits. The six point scale will indicate presence of the abnormal increase in muscle tone, ranging from 0 = no increase in tone to 4 = affected part in rigid flexion and extension. Higher scores on this assessment mean worse outcomes.

    Time frame: Assessment occurs at one cross-sectional timepoint within 2 weeks of research consent

  4. Nottingham Sensory Assessment (Erasmus MC)

    This test is used to understand sensory deficits of the upper extremity. Participants are exposed to distinct stimuli and asked to describe if the object is sharp or blunt and the location of the stimulus. A rater will determine if the reported sensation was absent, impaired, or normal.

    Time frame: Assessment occurs at one cross-sectional timepoint within 2 weeks of research consent

  5. National Institute of Health Stroke Scale

    This test provides information about overall stroke severity. The test includes a series of different questions which allow for the assessment of level of consciousness, vision, facial, arm, and leg motor weakness, sensation, coordination, and language expression and reception. Score range from 0 to 42. Higher scores on this assessment mean worse outcomes.

    Time frame: Assessment occurs at one cross-sectional timepoint within 2 weeks of research consent

  6. Montreal Cognitive Assessment (MoCA)

    This test is used to assess cognitive dysfunction by testing multiple different cognitive domains including attention and concentration, executive functions, memory, language, visuospatial skills, conceptual thinking, calculations, and orientation. Scores range from 0 to 30 with higher scores meaning better cognitive outcome.

    Time frame: Assessment occurs at one cross-sectional timepoint within 2 weeks of research consent

  7. Patient Health Questionnaire 9 (PHQ-9)

    This questionnaire is used to screen, diagnose, and monitor post stroke depression. The questionnaire includes a series of questions which allow a participant to self-report how often he/she has been experiencing symptoms of depression. Scores range from 0 to 27 with higher scores meaning worse depression.

    Time frame: Assessment occurs at one cross-sectional timepoint within 2 weeks of research consent

  8. History of TBI

    This questionnaire is used to collect information about the participant's injury history to his/her head. Participants are asked how many head injuries they have sustained, if any of these events led to loss of consciousness, and a description of their worst head injury.

    Time frame: Assessment occurs at one cross-sectional timepoint within 2 weeks of research consent

  9. Barthel Index

    This test provides information about the participant's level of independence in performing activities of daily living (ADLs). The test includes a series of questions which can be asked of the participant or a caregiver. Scores range from 0 to 100 with higher scores meaning better outcome.

    Time frame: Assessment occurs at one cross-sectional timepoint within 2 weeks of research consent

  10. Modified Rankin Scale

    This scale is used to measure the degree of disability based on functional status. The scale involves a series of questions asked to determine the degree of disability a participant is experiencing at the current timepoint. Scores range from 0 to 6 with higher scores meaning worse outcome.

    Time frame: Assessment occurs at one cross-sectional timepoint within 2 weeks of research consent

  11. Defense and Veterans Pain Rating Scale

    This scale is used to measure a participant's impression of the pain he/she is feeling at the time of assessment. The participant is asked to rate the pain on a scale of 0 to 10, with 0 indicating no pain and 10 being "as bad as it could be".

    Time frame: Assessment occurs at one cross-sectional timepoint within 2 weeks of research consent

  12. Manual Muscle Testing

    This assessment is used to measure the strength of the participant's muscles in his/her upper extremities. Participants are asked to maximally contract these muscles and the force produced is recorded by a dynamometer.

    Time frame: Assessment occurs at one cross-sectional timepoint within 2 weeks of research consent

06

Study locations

1 of 1 sites recruiting
  • Providence VA Medical Center
    Providence, Rhode Island 02908, United States
    Recruiting
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT05993221
Lead sponsor
Providence VA Medical Center
Responsible party
David Lin (Neurologist, Core Investigator, Providence VA Medical Center) — Principal investigator
First posted
Aug 15, 2023
Start date
Sep 5, 2023
Primary completion
Sep 2027 (estimated)
Completion
Sep 2027 (estimated)
Last update
Jun 6, 2025

Study contacts

Jennifer Hebert, BS
Contact
jennifer.hebert@va.gov
401-273-7100 ext. 14351
Kelly Rishe, OT
Contact
kelly.rishe@va.gov
401-273-7100

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion